Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Air Vice-Marshal Sir Ralph Jackson significantly advanced dialysis technology in the UK.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Significant facial gender transformation requires surgery, not nonsurgical methods.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Researchers found a genetic region that influences the number of coat layers in dogs.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

The study found that p63 needs signals from morphogens to help skin cells differentiate properly.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Most women have a widow's peak and specific hairline features useful for designing hair restoration surgery.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Overweight women with PCOS are more likely to have excess male hormones.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Women with alopecia may have a higher chance of getting thyroid cancer.

Women of color in Northern Manhattan view hair care as important to their identity and culture, and education on harmful chemicals in hair products is needed.